Applying the likelihood ratio concept in external quality assessment for ANCA

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Are the benefits of External Quality Assessment (EQA) recognized beyond the echo chamber?
4. Reviews
5. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part I – EQA in general and EQA programs in particular
6. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part II – EQA cycles
7. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples
8. Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories
9. Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants
10. Opinion Papers
11. Not all biases are created equal: how to deal with bias on laboratory measurements
12. Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases
13. General Clinical Chemistry and Laboratory Medicine
14. Evaluation of performance in preanalytical phase EQA: can laboratories mitigate common pitfalls?
15. Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)
16. The different serum albumin assays influence calcium status in haemodialysis patients: a comparative study against free calcium as a reference method
17. Measurement of 1,25-dihydroxyvitamin D in serum by LC-MS/MS compared to immunoassay reveals inconsistent agreement in paediatric samples
18. Knowledge among clinical personnel on the impact of hemolysis using blood gas analyzers
19. Quality indicators for urine sample contamination: can squamous epithelial cells and bacteria count be used to identify properly collected samples?
20. Reference Values and Biological Variations
21. Biological variation of cardiac biomarkers in athletes during an entire sport season
22. Increased specificity of the “GFAP/UCH-L1” mTBI rule-out test by age dependent cut-offs
23. Cancer Diagnostics
24. An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors
25. Cardiovascular Diseases
26. Comparative evaluation of peptide vs. protein-based calibration for quantification of cardiac troponin I using ID-LC-MS/MS
27. Infectious Diseases
28. The potential role of leukocytes cell population data (CPD) for diagnosing sepsis in adult patients admitted to the intensive care unit
29. Letters to the Editor
30. Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptide
31. Does blood tube filling influence the Athlete Biological Passport variables?
32. Influence of data visualisations on laboratorians’ acceptance of method comparison studies
33. An appeal for biological variation estimates in deep immunophenotyping
34. Serum free light chains reference intervals for the Lebanese population
35. Applying the likelihood ratio concept in external quality assessment for ANCA
36. A promising new direct immunoassay for urinary free cortisol determination